"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Penicilline","Ampicillina",4061,"1.3","1.0","1.7"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Aminoglicosidi (alto dosaggio)","Streptomicina",2842,"35.4","33.6","37.1"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Aminoglicosidi (alto dosaggio)","Gentamicina",2957,"39.9","38.1","41.7"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Glicopeptidi","Vancomicina",4109,"1.6","1.2","2.0"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Glicopeptidi","Teicoplanina",4078,"1.8","1.4","2.2"
